Clinical trial

Incretin-based Drugs and Pancreatic Cancer

NCT02475499

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-03-01

PhaseN/A

Study timeline

Study start (unknown)2014-03-01Date precision: month

Registry last updated2016-03-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

DPP-4 inhibitorsDRUG

GLP-1 analogsDRUG

SulfonylureasDRUG

ThiazolidinedionesDRUG

Alpha-glucosidase inhibitorsDRUG

MeglitinidesDRUG

Sponsors & collaborators

Canadian Network for Observational Drug Effect Studies, CNODESlead sponsor

Drug Safety and Effectiveness Network, Canadacollaborator

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02475499 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.